Luxana Biotech Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $5.94M
Latest Deal Amount
  • Investors
  • 5

Luxana Biotech General Information

Description

Developer of a medical platform intended to research and develop medical drugs. The company's platform specializes in developing nucleic acid drugs to reduce liver toxicity by modifying the base through its antisense toxicity reduction and array design technology, enabling hospitals to get therapeutic drugs necessary to improve diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • C907 9F Building C, Techno-Alliance Complex
  • 2-8 Yamadaoka, Suita
  • Osaka, 565-0871
  • Japan
+81 00-0000-0000

Luxana Biotech Timeline

201820192020
Date FoundedFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Luxana Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 10-Feb-2020 $5.94M 00.000 Completed Generating Revenue
1. Early Stage VC 01-Mar-2018 00000 00000 Completed Generating Revenue
To view Luxana Biotech’s complete valuation and funding history, request access »

Luxana Biotech Executive Team (1)

Name Title Board Seat Contact Info
Hideaki Sato Chief Executive Officer & President
To view Luxana Biotech’s complete executive team members history, request access »

Luxana Biotech Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mizuho Venture Capital Venture Capital Minority 000 0000 000000 0
Nissan Chemical Corporation Minority 000 0000 000000 0
Senshu Ikeda Capital Other Minority 000 0000 000000 0
Summit Pharmaceuticals International Corporation Minority 000 0000 000000 0
Osaka University Venture Capital Venture Capital Minority 000 0000 000000 0
To view Luxana Biotech’s complete investors history, request access »